16.09.2011 • News

Bayer To Realign Diagnostics Business

Bayer is planning a restructuring of its diagnostics business, according to a report in the Financial Times Deutschland. The German pharmaceutical giant has been reportedly looking for a buyer for the Medical Imaging division, while the X-Ray contrast agents business may be merged into the Medical Care division.

The sale of the Medical Imaging division is expected to affect 100 employees who, as per the report, have already been notified of an impending sale. The diagnostics business was acquired in 2006 as part of Schering.

Interview

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.